ArticlePloS one2018

Chronic kidney disease (CKD) patients are exposed to more proton pump inhibitor (PPI)s compared to non-CKD patients.

Hee Jeong Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.